Pneumococcal vaccine and patients with pulmonary diseases.
Chronic pulmonary diseases are chronic diseases that affect the airways and lung parenchyma. Examples of common chronic pulmonary diseases include asthma, bronchiectasis, chronic obstructive lung disease, lung fibrosis, sarcoidosis, pulmonary hypertension, and cor pulmonale. Pulmonary infection is considered a significant cause of mortality in patients with chronic pulmonary diseases. Streptococcus pneumoniae is the leading isolated bacteria from adult patients with community-acquired pneumonia, the most common pulmonary infection. Vaccination against S. pneumoniae can reduce the risk of mortality, especially from more serious infections in both immunocompetent and immunocompromised patients. Patients with chronic pulmonary diseases who take steroids or immunomodulating therapy (eg, methotrexate, anti-tumor necrosis factor inhibitors), or who have concurrent sickle cell disease or other hemoglobinopathies, primary immunodeficiency disorders, human immunodeficiency virus infection/acquired immunodeficiency syndrome, nephrotic syndrome, and hematologic or solid malignancies should be vaccinated with both 13-valent pneumococcal conjugate vaccine and the pneumococcal polysaccharide vaccine 23-valent.
University of Illinois at Chicago, Division of Pulmonary and Critical Care, Chicago. Electronic address: mmirsae@uic.edu.
Mehdi
M
Mirsaeidi
University of Illinois at Chicago, Division of Pulmonary and Critical Care, Chicago.
Golnaz
G
Ebrahimi
University of Louisville, Department of Health, Louisville, Ky.
Mary Beth
MB
Allen
University of Milan Bicocca, Department of Health Science, Clinica Pneumologica, AO San Gerardo, Monza, Italy.
Stefano
S
Aliberti
D002908:Chronic Disease; D006801:Humans; D008171:Lung Diseases / Q000150:complications*; D022242:Pneumococcal Vaccines; D011018:Pneumonia, Pneumococcal / Q000209:etiology / Q000517:prevention & control*; D012307:Risk Factors; D014611:Vaccination / Q000379:methods / Q000592:standards
C538862:13-valent pneumococcal vaccine; C414006:23-valent pneumococcal capsular polysaccharide vaccine; D022242:Pneumococcal Vaccines
Invasive pneumococcal disease; Pneumococcal; Pneumonia; Pulmonary; Streptococcus pneumoniae; Vaccination